Promus PREMIER™ H7493952824250Recalls & reported problems
Boston Scientific Corporation · Everolimus-Eluting Platinum Chromium Coronary Stent System · Class 3 · Implant
All models of Promus PREMIER (56)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 08714729844839), received between Dec 6, 2016 and Aug 6, 2018 — classified as 1 injury, 3 malfunctions.
The most frequently reported specific device problem is “Device Dislodged or Dislocated” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Device Dislodged or Dislocated3
- Bent1
- Device Damaged Prior to Use1
Patient problems
- No Consequences Or Impact To Patient3
- No Patient Involvement1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 6, 2018Device Dislodged or Dislocated; Device Dislodged or Dislocated
IT WAS REPORTED THAT STENT DISLODGEMENT OCCURRED. THE TARGET LESION WAS LOCATED IN THE DISTAL RIGHT CORONARY ARTERY. A 2.50X24MM PROMUS PREMIER¿ DRUG-ELUTING STENT WAS ADVANCED BUT FAILED TO CROSS THE LESION AFTER SEVERAL ATTEMPTS. THE DEVICE WAS REMOVED INTACT FROM THE PATIENT; HOWEVER, WHEN THE DEVICE WAS RE-PREPPING FOR RE-ADVANCED, IT WAS NOTED THAT THE STENT CAME OFF THE BALLOON OUTSIDE THE PATIENT. THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. THERE WERE NO PATIENT COMPLICATIONS NOR HARM REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7753377 ↗MalfunctionJun 26, 2018Device Damaged Prior to Use; Device Dislodged or Dislocated; Device Damaged Prior to Use; Device Dislodged or Dislocated
IT WAS REPORTED THAT STENT DISLODGEMENT OCCURRED. A 2.50X24MM PROMUS PREMIER¿ DRUG-ELUTING STENT WAS SELECTED FOR USE TO TREAT THE LESION. HOWEVER, IT WAS NOTED THAT THE STENT FELL OFF THE BALLOON. THE DEVICE WAS NOT USED INSIDE THE PATIENT. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS WAS OKAY.
Patient problems: No Patient Involvement
MAUDE report 7637856 ↗MalfunctionJun 28, 2017Bent; Bent
IT WAS REPORTED THAT STENT DAMAGE OCCURRED. THE TARGET LESION WAS LOCATED IN THE TORTUOUS LEFT ANTERIOR DESCENDING ARTERY (LAD). AFTER ROTABLATION WAS PERFORMED AND A 2.50X16MM STENT WAS IMPLANTED, A 2.50X24MM PROMUS PREMIER¿ DRUG-ELUTING STENT WAS ADVANCED; HOWEVER, A LOT OF RESISTANCE WAS ENCOUNTERED. THE DEVICE WAS REMOVED FROM THE PATIENT'S BODY AND THE TIP WAS NOTED TO BE A LITTLE BIT FLARED OUT. THE PROCEDURE WAS COMPLETED WITH ANOTHER 2.50X24MM PROMUS PREMIER¿ DRUG-ELUTING STENT. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS WAS FINE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6673099 ↗InjuryDec 6, 2016Device Dislodged or Dislocated; Device Dislodged or Dislocated
IT WAS REPORTED THAT STENT DISLODGMENT OCCURRED. THE TARGET LESION WAS LOCATED IN A SAPHENOUS VEIN GRAFT (SVG) IN A CORONARY ARTERY. A 2.50X24MM PROMUS PREMIER¿ DRUG-ELUTING STENT WAS ADVANCED TO TREAT THE LESION WITH THE USE OF A GUIDEZILLA GUIDE EXTENSION CATHETER. HOWEVER, WHEN THE DEVICE WAS PULLED BACK INTO THE GUIDEZILLA, THE STENT BECAME DISLODGED. ANOTHER STENT WAS THEN ADVANCED AND DEPLOYED, SMASHING THE DISLODGED STENT INTO THE VESSEL WALL, AND THE PROCEDURE WAS COMPLETED. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS WAS STABLE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6149432 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page